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Neuronal apoptosis inhibitory protein (NAIP)/NOD-like receptor (NLR) containing a caspase
activating and recruitment domain (CARD) 4 (NLRC4) inflammasome complexes are acti-
vated in response to proteins from virulent bacteria that reach the cell cytosol. Specific
NAIP proteins bind to the agonists and then physically associate with NLRC4 to form an
inflammasome complex able to recruit and activate pro-caspase-1. NAIP5 and NAIP6 sense
flagellin, component of flagella from motile bacteria, whereas NAIP1 and NAIP2 detect
needle and rod components from bacterial type III secretion systems, respectively. Active
caspase-1 mediates the maturation and secretion of the pro-inflammatory cytokines, IL-1β
and IL-18, and is responsible for the induction of pyroptosis, a pro-inflammatory form of
cell death. In addition to these well-known effector mechanisms, novel roles have been
described for NAIP/NLRC4 inflammasomes, such as phagosomal maturation, activation of
inducible nitric oxide synthase, regulation of autophagy, secretion of inflammatory media-
tors, antibody production, activation of T cells, among others. These effector mechanisms
mediated by NAIP/NLRC4 inflammasomes have been extensively studied in the context of
resistance of infections and the potential of their agonists has been exploited in therapeutic
strategies to non-infectious pathologies, such as tumor protection. Thus, this review will
discuss current knowledge about the activation of NAIP/NLRC4 inflammasomes and their
effector mechanisms.
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INTRODUCTION
Inflammasomes are multiprotein platforms containing specialized
cytosolic sensors for a wide range of pathogen-associated molecu-
lar patterns (PAMPs) or damage-associated molecular patterns
(DAMPs) that are able to activate the inflammatory caspase-1
and caspase-11 (caspase-4 in humans) in a manner dependent
or independent of adaptor molecules (1–4). Inflammasomes are
composed of a cytosolic receptor from the nucleotide-binding
domain-leucine-rich repeat (NBD-LRR) [also named NOD-like
receptors (NLR)] or the pyrin and HIN domain-containing pro-
tein (PYHIN) families; the adaptor molecule ASC [apoptosis-
associated speck-like protein containing a caspase activating and
recruitment domain (CARD)]; and pro-caspase-1 or pro-caspase-
11. AIM2 is the only member of the PYHIN family described
to form inflammasomes. AIM2 is composed of two domains:
a C-terminal HIN200 domain and an N-terminal pyrin (PYD)
domain. The members of the NLR family contain three domains:
a central NBD that is responsible for protein oligomerization and
common to all members; a C-terminal region composed of LRR
sequences that are supposed to sense PAMPs or DAMPs; and an
N-terminal portion that is responsible for the specificity of their
molecular interactions and, therefore, their effector functions.
The NLR proteins can be classified into NLRBs [NLR contain-
ing the baculovirus inhibitory (BIR) domain], NLRCs (NLRs
containing the CARD domain), and NLRPs (NLRs containing the
PYD domain) (5).
NOD-like receptor proteins are maintained in an autoinhib-
ited state under physiological conditions. After agonist recogni-
tion, they undergo a conformational rearrangement, triggering the
NBD domains. Then, these proteins expose the effector domain to
allow the assembly of oligomeric complexes. The NLRs that lack
the CARD domain to recruit and activate pro-caspases-1 and 11
require the assistance of the adapter molecule ASC, which con-
tains the PYD and CARD domains for binding caspases (6, 7).
The NLRC members can directly recruit pro-caspase-1 through
homotypical interactions between CARD domains, or they can
recruit the adaptor ASC to activate caspase-1 (2). The canonical
effector mechanisms mediated by caspase-1 are the maturation
and secretion of IL-1β and IL-18 and the induction of pyroptosis,
a pro-inflammatory form of cell death. Furthermore, caspase-11
seems to be able to induce pyroptosis (8).
After a decade of inflammasome discovery (9), little is known
about the molecular complex formed by most members of the
NLR family. AIM2, NLRP3, and NLRC4 are the best-characterized
inflammasome complexes. The importance of these complexes
to control bacterial, viral, fungal, and protozoan infections and
their influence in inflammatory processes are gaining prominence
in the literature, although their precise activation mechanisms
remain to be elucidated. Here, we focus on NLRC4 inflamma-
somes, the recent advances in the understanding of their assem-
bly and the consequences of their activation to the immune
response.
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ASSEMBLY AND ACTIVATION OF NAIP/NLRC4
INFLAMMASOMES
The first reports about the recognition of cytosolic flagellin,
the monomeric subunit from flagella present in motile bacte-
ria, demonstrated that the neuronal apoptosis inhibitory protein
(NAIP)-5 was responsible for the detection of cytosolic flagellin
from L. pneumophila and for the restriction of infection (10,
11). In the same year, studies with S. typhimurium revealed that
another member of the NLR family, NLRC4, was also able to
detect cytosolic flagellin (12, 13). NLRC4 was first described in
2001 as a mammalian protein homologous to CED4 of C. ele-
gans, whose function is to recruit and activate caspases through its
CARD domain (14, 15). Because of the ability to activate caspase-
1, previously known as interleukin-1-converting enzyme (ICE),
NLRC4 was first named IPAF (ICE-protease-activating factor).
Although the involvement of NLRC4 in the control of infections
was previously reported, their agonists remained a mystery until
2006.
Flagellin is one of the best-characterized agonists of the innate
immune system. Extracellular flagellin is recognized by TLR5
(16) but it can be delivered to the cell cytosol though the secre-
tion systems present in virulent bacteria strains, such as the S.
typhimurium type III secretion system (T3SS SPI-1) and L. pneu-
mophila type IV (T4SS). In the cell cytosol, flagellin induces the
formation of the NAIP5/NLRC4 inflammasome, leading to the
subsequent activation of caspase-1 (17, 18, 23). Notably, the acti-
vation NAIP5/NLRC4 inflammasomes by cytosolic flagellin occurs
independently of TLR5 (20),and these two receptors recognize dis-
tinct regions of flagellin (16). TLR5 senses a region present in the
D1 domain of the protein, whereas the amino acid sequences rec-
ognized by NAIP5/NLRC4 inflammasomes are in the D0 domain
of the molecule (18, 23, 19, 21, 22).
Previous studies have pointed to the involvement of NAIP5
in controlling L. pneumophila flagellated bacteria (24, 25) and
to the involvement of NLRC4 in caspase-1 activation and the
induction of macrophage death (14, 15), although the role of
flagellin in these processes was unidentified at that time. The
simultaneous demonstration of cytosolic flagellin recognition
by NAIP5 and NLRC4 prompted a model that proposed the
existence of two distinct inflammasomes that recognize slight
differences in the structure of flagellin (10–13). In 2008, with
the advent of NAIP5-deficient mice, Lightfield and collabora-
tors confirmed that NAIP5 is required for NLRC4-containing
inflammasome activation in response to L. pneumophila infection
in a flagellin-dependent manner; however, the NLRC4-mediated
macrophage responses against S. typhimurium were only partially
dependent on NAIP5 (21). A subsequent work from the same
group demonstrated that the differential requirement for NAIP5
in response to S. typhimurium and L. pneumophila infection is
not due to intrinsic differences between distinct flagellins, as a
genetically engineered L. pneumophila developed to express the S.
typhimurium flagellin also activated the NLRC4 inflammasome in
a manner strictly dependent on NAIP5 (17). These data indicated
that another agonist from S. typhimurium could activate NLRC4
independent of the presence of NAIP5. In fact, these studies con-
firm that NLRC4 responds to the S. typhimurium PrgJ protein
independently of NAIP5, thus explaining why NLRC4-mediated
responses to S. typhimurium are only partially dependent
on NAIP5.
The inflammasome structure formed by these proteins was
unveiled only recently when two independent groups proposed
a model for NAIP5/NLRC4 inflammasome assembly (18, 23).
Using the transfection of inflammasome components and micro-
bial molecules in HEK 293T cells or followed by biochemical
assays, the authors demonstrated the ability of flagellin from
different bacterial species to bind NAIP5. This interaction was
dependent on the three leucine residues of the C-terminal por-
tion of flagellin, confirming prior data (17). Furthermore, after
the recognition of flagellin, a physical association between NAIP5
and NLRC4 was demonstrated, resulting in the formation of an
oligomeric complex. Reconstitution experiments using truncated
receptor variants showed that NAIPs are upstream of NLRC4 and
suggest that they interact via the NBD domain. Notably, NAIP6
worked similarly to NAIP5, as it induced the oligomerization of
NLRC4 in response to flagellin, and this could explain the response
of NAIP5−/− cells to high concentrations of flagellin. NAIP1 and
NAIP2 also recruit NLRC4 in response to the bacterial needle and
inner rod proteins of T3SS, respectively (18, 23). Therefore, NAIP
proteins seem to be the universal sensors of cytosolic flagellin and
secretory complex proteins, whereas NLRC4 acts as an adapter
molecule and is responsible for the recruitment and activation of
caspase-1. It is noteworthy that there is only one functional NAIP
found in humans, which is not activated by flagellin but is able to
detect needle proteins of T3SS, similar to NAIP1 (18).
Despite these recent contributions to the understanding of
NAIP/NLRC4 assembly, the molecular requirements of bacte-
rial proteins for the formation of the inflammasome complex
still requires further clarification. Lightfield et al. (21) originally
demonstrated that the final 35 amino acids of the C-terminal
portion of the flagellin molecule are essential for the activation
of NAIP5. Moreover, the replacement of three leucine residues
by alanine in this region abrogated the potential of flagellin to
activate NAIP5. However, these studies were based on constructs
containing only the C-terminal portion of the flagellin struc-
ture. A recent study using whole flagellin with or without these
regions have shown that although the three leucine residues were
essential for the detection of the C-terminus, their involvement
seems to be less important for full-length flagellin recognition, as
whole flagellin containing three alanines instead of three leucines
still induces cell death and inflammasome complex formation,
although fewer complexes are formed (22). Surprisingly, although
the absence of the N-terminal domain does not affect the ability
of whole flagellin to interact with NAIP5, constructs containing
only N-terminus also retain the ability to activate NAIP5/NLRC4.
Thus, the molecular interaction between flagellin and NAIP5/6
still requires clarification. Moreover, although flagellin was found
inside the NAIP5/NLRC4 complex, as demonstrated by immuno-
precipitation (19, 26) and yeast two-hybrid (18) assays, providing
a basis for the model of direct interaction between flagellin and
NAIP5, our group recently demonstrated the ability of cytosolic
flagellin to activate a lysosomal pathway and the requirement of
cathepsin B for NLRC4-dependent IL-1β secretion and pyroptosis
(27). These observations raise the possibility that NAIP5/NLRC4
can also be activated by cytosolic alterations induced by the
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presence of flagellin, as proposed for the activation of the NLRP3
inflammasome (28).
Challenging prior models that hypothesized that LRR domains
are responsible for the detection of NLR agonists, a recent study
found that these domains are dispensable for the ligand specificity
of NAIPs (26). By using a series of chimeric proteins in which
the N-terminal domains of NAIP5 or NAIP6 were fused to the
C-terminal domains of NAIP2 or vice-versa, the authors demon-
strated that NAIP proteins lost the ability to oligomerize with
NLRC4 only when NOD domain-associated α-helical domains
were absent, suggesting that ligand specificity maps to this region.
Interestingly, a similar region in NLRC4 was recently associated
with its autoinhibition (29), whereas LRR domain from NAIPs
was shown to be required for the maintenance of this protein
in an autoinhibited conformation (19). Despite, these unsolved
pieces of the puzzle, it has been demonstrated that the interaction
of NAIPs with their ligands and the association of NLRC4 with
NAIPs induce conformational changes in these molecules that
enable their oligomerization and activation (22, 30). Predicted
models for the NAIP/NLRC4 inflammasome suggest that these
complexes contain an excess of NLRC4 for each NAIP protein (22,
26) and that NLRC4 molecules are able to recruit and activate
caspase-1 either directly or through an ASC adapter. The associ-
ation of pro-caspase-1 with an inflammasomes-containing ASC
allows its autoproteolytic cleavage to become an enzymatically
active heterodimer capable of processing pro-IL-1β and pro-IL-
18 into mature cytokines (2). In contrast, an ASC-independent
complex activates caspase-1 without autoproteolysis, which is suf-
ficient for caspase-1 to target a distinct subset of substrates critical
for the induction of pyroptosis.
CANONICAL EFFECTOR MECHANISMS INDUCED BY
NAIP/NLRC4 INFLAMMASOMES
PYROPTOSIS
The NAIP5/NLRC4 inflammasome is perhaps the best-studied
inflammasome complex with regard to resistance to infections.
Their involvement has been reported against infections such as S.
typhimurium (31, 32), L. pneumophila (25), P. aeruginosa (33, 34),
Y. pestis (35), S. flexneri (36), and A. veronii (37). NAIP/NLRC4-
mediated responses are related to the restriction of bacterial
growth due to the active caspase-1-mediated canonical and non-
canonical effector mechanisms, highlighting the importance of
this inflammasome as a host defense mechanism against a large
number of bacterial infections. The best elucidated effector mech-
anisms involved in the control of infections mediated by caspase-1
are the secretion of inflammatory cytokines IL-1β and IL-18 and
the induction of pyroptosis (38).
The term pyroptosis (from the Greek “pyro” meaning fire or
fever, and “ptosis” to a fault) was coined in 2001 to describe a
pro-inflammatory programed cell death during S. typhimurium
infection (39). Morphological and biochemical changes dis-
played by S. typhimurium-infected dying cells were more closely
related to those found in classic necrosis compared with those
observed during apoptosis, including the following: (1) diffuse
DNA fragmentation with no chromatin condensation; (2) early
loss of membrane integrity observed by the simultaneous uptake
of annexin V with an impermeable membrane dye; (3) lactate
dehydrogenase (LDH) release, suggesting a loss of intracellular
content; and (4) independence of any apoptotic caspase. Although
cells dying by pyroptosis displayed features of necrosis with an
inflammatory outcome, the authors found that this process was
highly regulated by active caspase-1, as the addition of inhibitors
of caspase-1 (z-YVAD-fmk) abolished S. typhimurium-induced
cell death.
The induction of pyroptosis by pathogenic bacteria depends
on an active secretion system that translocates bacterial proteins
into the cell cytosol, such as the T3SS (SPI-1) of S. typhimurium
and type IV (T4SS) of L. pneumophila (12, 13, 40–42). Mutant
L. pneumophila (43) or P. aeruginosa (34, 44) lacking flagellin
fail to activate caspase-1 and, therefore, are not able to induce
pyroptosis and IL-1β secretion in infected macrophages. Accord-
ingly, the transfection of purified flagellin from L. pneumophila
and S. typhimurium directly into the cell cytosol is sufficient
to trigger caspase-1-dependent pore formation, pyroptosis, and
IL-1β secretion (45, 46). Importantly, infection with the non-
flagellated bacteria S. flexneri also induces NLRC4-mediated
pyroptosis, most likely in response to the inner rod component
of T3SS (36).
Although the molecular mechanisms that regulate pyroptosis
remain to be elucidated, the model of S. typhimurium infec-
tion has given us important knowledge about this form of cell
death. The cell lysis observed during pyroptosis seems to result
from a highly regulated process of pore formation in the plasma
membrane (45, 46). Pores dissipate cellular ionic gradients but
allow the retention of larger cytoplasmic constituents, leading
to increased liquid osmotic pressure and water influx. These
events are followed by cell swelling and subsequent osmotic lysis
with the release of intracellular contents, which are potentially
inflammatory (45, 46). Caspase-1-dependent DNA cleavage also
occurs during pyroptosis (45, 47). However, the DNA cleavage
observed during S. typhimurium-induced pyroptosis is indepen-
dent of caspase-activated DNase (CAD) (45, 47), unlike what is
observed during apoptosis, in which the proteolysis of inhibitor
of CAD (ICAD) by apoptotic caspases mediates the release of
CAD to the nucleus, where it cleaves DNA between nucleosomes.
Therefore, pyroptotic cells do not display the typical pattern of
oligonucleosomal fragmentation observed during apoptosis, a fact
that can be used to distinguish between these two processes of cell
death (48).
There is good evidence implicating pyroptosis as an important
host defense mechanism mediated by NAIP/NLRC4 that clears
intracellular pathogens in vitro. The death of infected macrophages
by pyroptosis seems to correlate with a rapid loss of the replicative
niche and high bacterial loads are recovered from macrophages
deficient in components of inflammasomes or infected with
mutant bacterial strains that fail to trigger their activation
[reviewed by Bortoluci and Medzhitov (1) and Bergsbaken et al.
(49)]. Moreover, a study conducted in vivo demonstrated that the
NLRC4-dependent flagellin-mediated lysis of bacteria-containing
macrophages not only results in the early loss of the intracel-
lular replication niche but also creates an inflammatory milieu
with the recruitment of effector cells to the infection site, which
are involved in pathogen clearance (32). Although the possible
targets of caspase-1 and caspase-11 mobilized during pyroptosis
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remain unidentified, the studies involving NAIP/NLRC4 hugely
contribute to the idea that this inflammatory form of cell death is
an important effector mechanism against infections.
IL-1β AND IL-18 SECRETION
IL-1 was the first identified cytokine and has been related to
several inflammatory processes. IL-1 plays a role in virtually all
cells and organs, ranging from fever and resistance to microor-
ganisms to the activation of the hypothalamus–pituitary–adrenal
axis (HPA) (50–56). IL-18 was first described in 1989 as a
potent IFN-γ-inducing factor and an important component of
polarized type-1 T helper cells (Th1) and type-1 macrophages
(M1) responses, cells with a pro-inflammatory profile (57–59).
Macrophages, monocytes, lymphocytes, keratinocytes, microglia,
neutrophils, dendritic cells, and other cells are described as impor-
tant sources of IL-1β and IL-18 (60–64). IL-18 and IL-1β have
similar processing; they are both synthesized in an inactive form
that requires processing by active caspase-1 to become biologically
active (61, 65, 66). Although extensively studied, the mechanism
responsible for IL-1β and IL-18 release has not been fully elu-
cidated. These cytokines can be passively released during cell
lysis; however, there is recent evidence supporting the existence
of active mechanisms involved in the secretion of IL-1β and IL-18,
such as caspase-1-induced membrane pores, vesicle shedding and
lysosomal exocytosis (45, 49).
Although the precise effector mechanisms of IL-1β and IL-
18 remain to be elucidated, these cytokines have been reported
to be important mediators induced by NAIP/NLRC4 to host
resistance to bacterial infections (67). In addition to the effects
of IL-1β and IL-18 in the activation and recruitment of innate
immune cells, these cytokines have important roles in the activa-
tion and differentiation of T lymphocytes (52). IL-1β and IL-18
have been shown to drive the establishment of T CD4+ adap-
tive responses in mice and in humans and are responsible for
the differentiation of Th17 and Th1, respectively (68–70). How-
ever, little is known about the involvement of IL-1β and IL-18 in
NAIP/NLRC4-induced adaptive immune responses. Kupz et al.
demonstrated that IL-18, when produced by the activation of
NLRC4 during infection by S. typhimurium, is required for the
activation of non-cognate CD8+ T cells and the production of
IFN-γ (71), supporting a role for this cytokine in the induction of
cellular responses.
Additional evidence of the role of NAIP/NLRC4 in the acti-
vation of T cells came from an experimental vaccination with
irradiated flagellin-expressing tumor cells. Authors demonstrated
that the immunization of mice with flagellin-fused tumor cells
induced tumor-specific CD4+ and CD8+ T cell responses and
prevented parental tumor growth. Despite the well-known role of
TLR5, the recognition of flagellin by the NAIP5/NLRC4 inflamma-
some was also required for the induction of a protective CD8+ T
cell response and tumor suppression. Although the NAIP5/NLRC4
inflammasome-mediated IL-1β secretion in response to the injec-
tion of flagellin-modified tumor cells, it is unclear whether the
involvement of this cytokine was necessary for the success of
this immunotherapy. The role of IL-1β and IL-18 in tumorige-
nesis remains controversial. There is strong evidence supporting
pro-tumorigenic properties of these cytokines via the induction
of chronic inflammation. Although the induction of Tregs and
Th17 could impair the immune response against tumor cells, it
is reasonable to consider that the activation of Th1 and cyto-
toxic CD8 T cells by IL-1β and IL-18 may be beneficial to the
host (72, 73).
EMERGING EFFECTOR MECHANISMS MEDIATED BY THE
NAIP/NLRC4 INFLAMMASOME
HUMORAL EFFECTOR MECHANISMS
In addition to the well-characterized functions of NAIP/NLRC4
inflammasomes described above, non-canonical effector mech-
anisms have emerged. Recent data describe a range of effector
functions mediated by NAIP/NLRC4 inflammasomes that operate
independently of IL-1β, IL-18 and pyroptosis. The NAIP5/NLRC4
inflammasome has been implicated in the activation of phospholi-
pase A2 (cPLA2) with a consequent production of lipid mediators,
such as prostaglandins and leukotrienes (74). Authors demon-
strated that systemic cytosolic flagellin stimulation leads to an
“eicosanoid storm” that initiates inflammation and the loss of vas-
cular fluids, resulting in a very fast death in mice. Of note, these
effects are mediated by NAIP5/NLRC4 and occur independently
of IL-1β/IL-18 or pyroptosis.
Inflammasomes have also been implicated in the active secre-
tion of endogenous molecules known as DAMPs, challenging the
idea that these molecules are only passively released during the
process of cell lysis (75). IL-1α is an alarmin, whose release has
been recently linked to inflammasomes. Both IL-1β and IL-1α
present some common features, such as belonging to the same
family, synthesis in the cytoplasm and secretion by an uncon-
ventional pathway independent of the endoplasmic reticulum
and Golgi complex (55); additionally, they are released simulta-
neously by various stimuli, and they act on the same receptor,
IL-1R1, thus sharing some biological functions (52). However,
despite these similarities, there are some important differences
in the production, secretion, and function of these cytokines.
Unprocessed forms of both IL-1α and IL-1β are thought to be
produced in response to TLR ligands, but they have distinct activ-
ities. Unlike IL-1β, which needs to be processed by caspase-1
to become biologically active (65), the uncleaved form of IL-
1α is able to engage IL-1R1 (60, 76), although it’s full activity
seems to require cleavage by calpain (77). Although IL-1α is
not a substrate for caspase-1, there are some reports that have
demonstrated that macrophages from caspase-1-deficient mice
release less IL-1α (27, 78–80), suggesting the involvement of
inflammasomes.
The mechanism by which caspase-1 mediates IL-1α secretion
is still a matter of debate. A recent study demonstrated that the
requirement of inflammasomes for IL-1α secretion depends on
the nature of agonists (81). Caspase-1 has been described as a
shuttle that facilitates the secretion of leaderless proteins, such as
IL-1α (80). However, it is not clear whether active caspase-1 is
the shuttle itself or whether it activates another enginery that is
dependent on its activity, e.g., IL-1β (82) or IL-1R2 (77), as has
been proposed for the secretion of IL-1α in response to NLRP3
agonists. The involvement of NLRC4 inflammasomes in IL-1α
secretion is poorly understood. In one previous study, infection
by S. typhimurium resulted in NLRC4- and caspase-1-dependent
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secretion of IL-1α (81). Interestingly, in contrast with most of
the NLRP3 agonists, the secretion of IL-1α in response to S.
typhimurium was completely independent of ASC, indicating a
differential requirement for this adaptor molecule in cytokine
secretion in response to NLRC4 agonists, as IL-1β is entirely depen-
dent on ASC (2). However, Barry et al. showed that IL-1α initiates
the inflammatory response driven by L. pneumophila independent
of caspase-1 and NLRC4 (83). We recently reported that the acti-
vation of macrophages with purified flagellin inserted into lipidic
vesicles induced IL-1α secretion in a manner partially dependent
on caspase-1 and cathepsin B (27). Therefore, the reasons for
the discrepancies in the literature and the precise mechanisms
involved in the cross talk between IL-1α and NLRC4/caspase-1
axis remain to be addressed.
Another factor whose secretion has been linked to inflamma-
somes is the“High Mobility group box-1”(HMGB-1). HMGB-1 is
a nuclear protein involved in the regulation of nucleosome func-
tion and DNA transcription that functions as an inflammatory
mediator when released to the extracellular milieu (84). Lamkanfi
et al. reported a critical role for HMGB-1 secreted through the
NLRP3/ASC/caspase-1 axis in LPS-induced endotoxic shock (85).
Interestingly, macrophages infected with S. typhimurium released
significant amounts of HMGB-1 in a NLRC4 and caspase-1-
dependent manner but independently of ASC, which is similar
to previous reports of IL-1α secretion (81). During pyroptosis
induced by a variety of stimuli, including S. typhimurium infec-
tion, HMGB-1 did not undergo caspase-1-mediated processing
before its secretion, but extracellular HMGB-1 was hyperacety-
lated at the nuclear localization sequences (NLSs) (86). Because
this translational modification is essential for HMGB-1 translo-
cation from the nucleus to the cytoplasm (87, 88), HMGB-1
release upon inflammasome activation seems to be a coordi-
nated process. More recently, Nystrom et al. (89) reported that
NLRC4-mediated pyroptosis is the prevalent factor in the regula-
tion of HMGB-1 secretion, leading to the release of the chemo-
tactic acetylated HMGB-1 isoform without requiring TLR-derived
priming. Although the mechanisms by which inflammasome com-
ponents can regulate DAMPs secretion still need to be better
understood, DAMPs are already considered important therapeutic
targets because of their role in host resistance against infection and
their involvement in inflammatory disorders.
With respect to antibodies production NLRC4, NAIP5, and
caspase-1 have been reported to have a redundant role with TLR5
in the induction of total IgG (90) or IgG1 (91) against flagellin or
co-administered OVA and an additive effect to TLR5 in the induc-
tion of IgG2a (91). In the absence of MyD88, in which TLR5,
IL-1β, IL-1α, and IL-18 signaling is compromised, the production
of antibodies induced by flagellin was reduced but not abolished,
and a large amount of antibodies was still produced (91). The same
results were obtained with TLR5/caspase-1 double-knockout mice
(91), supporting previous data that demonstrated that no signifi-
cant difference was observed in specific anti-flagellin IgG titers in
mice deficient for IL-18 (92) or IL-1R (93). These reports suggest
that some yet-undiscovered mechanism that acts in addition to
TLR5 and inflammasome-mediated cytokines could be involved
in the adjuvant properties of flagellin, requiring new investigations
into this agonist.
CELLULAR EFFECTOR MECHANISMS
In addition to inflammatory mediators and cell death processes,
some cellular effector mechanisms mediated by NLRC4 have
emerged. Previous studies from our group described a require-
ment of NAIP5, NLRC4, and caspase-1 for the activation of
inducible nitric oxide synthase (iNOS) and nitric oxide (NO)
secretion in response to cytosolic flagellin (94). Interestingly,
cytosolic flagellin-induced iNOS activation is preserved in the
absence of MYD88, ruling out the participation of TLR5, IL-1β,
and IL-18. Moreover, NO secretion through the NAIP5/NLRC4-
caspase-1 axis in response to flagellin is involved in the control
of L. pneumophila (94) and S. typhimurium (unpublished data
from our group) by macrophages, pointing to this pathway as an
additional effector mechanism mediated by NAIP5/NLRC4.
Autophagy is another effector mechanism used by NAIP5/NLRC4
to control L. pneumophila. In the presence of NAIP5, NLRC4
macrophages present a rapid turnover of LC3+ L. pneumophila-
containing vesicles, preventing the establishment of secondary
infections (95). This response is mediated by the detection of fla-
gellin, and the inhibition of autophagy in macrophages infected
with flagellin-sufficient L. pneumophila increased the rate of
pyroptosis in these cells. These data confirm a previous study
that demonstrated that NLRC4 plays a role in the regulation of
autophagy by binding Beclin-1 in steady-state conditions (96).
Because the initiation of autophagy seems to precede the induc-
tion of pyroptosis, autophagy can be considered a pathway through
which macrophages raise the threshold of contaminants nec-
essary to result in the loss of cell by inflammatory cell death.
NAIP5/NLRC4 can also restrict flagellin-competent L. pneu-
mophila replication by promoting the delivery of L. pneumophila-
containing phagosomes (LCP) to lysosomes for degradation (43,
97). In the absence of NAIP5/NLRC4/caspase-1, LCP avoids fusion
with lysosomes, which allows the pathogen to exponentially repli-
cate inside macrophages. This effect is dependent on caspase-1-
mediated caspase-7 processing and does not require IL-1β/IL-18
and the classical apoptosis pathway involving caspase-8 and -9
(98). These data corroborate a previous report that demonstrated
a requirement of NLRC4, caspase-1, and ASC for caspase-7 pro-
cessing during infection with flagellin-competent S. typhimurium
(99). NLRC4 and ASC-dependent caspase-8 proteolysis was also
reported during S. typhimurium infection (100). Interestingly,
caspase-8 contributes to Salmonella-induced IL-1β production,
but it is dispensable for inducing pyroptosis, whereas caspase-1
processes pro-IL-1β and coordinates pyroptosis. These data high-
light the fact that inflammasomes are dynamic complexes that are
able to recruit distinct members of the caspase family to induce
diverse effector functions in response to Salmonella infection.
Similar to what has been demonstrated during apoptosis (101,
102) and necrosis (103), the cleavage of PARP1 (also called
ARTD1) was also observed during pyroptosis induced by S.
typhimurium (104). PARP1 processing in S. typhimurium-infected
macrophages was abrogated in Nlrc4−/− but not in Nlrp3−/− cells,
consistent with the role of the NAIP5/NLRC4 inflammasome in
the induction of pyroptosis during S. typhimurium infection (12,
31, 105). PARP1 is a nuclear chromatin-associated multifunctional
enzyme that catalyzes the polymerization of ADP-ribose units
from donor NAD+ molecules (106, 107). Although it has been
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historically studied in the context of genotoxic stress signaling
and consequent apoptosis, PARP1 has been related to chromatin
structure regulation, transcription, and chromosomal organiza-
tion (108, 109). Previous reports showed that inflammasomes are
able to use PARP1 to induce the transcription of NF-κB-dependent
target genes independently of any type of programed cell death
(110). Upon LPS stimulation, caspase-7 is activated by caspase-1,
which is translocated to the nucleus to induce PARP1 cleavage at
the promoters of a subset of NF-κB-dependent target genes that are
negatively regulated by PARP1. Mutating the PARP1 cleavage site
D214 renders PARP1 uncleavable and inhibits PARP1 release from
chromatin and, therefore, chromatin decondensation, thereby
restraining the expression of cleavage-dependent NF-κB target
genes, such as il-6, cfs2, and lif, but not ip-10 (110). Preliminary
and unpublished data from our group suggest the involvement
of caspase-1-dependent PARP1 cleavage in iNOS gene expression
upon cytosolic flagellin stimulation, as iNOS expression is signifi-
cantly reduced in macrophages that harbor non-cleavable PARP1
(D214N). This is important evidence of the involvement of inflam-
masomes in epigenetic regulation and gene expression, although
many of these outputs require further evaluation.
An important process of lysosomal exocytosis occurs dur-
ing pyroptosis. Bergsbaken and Cookson (111) demonstrated
that caspase-1-mediated pore formation induced during S.
typhimurium infection promotes an influx of extracellular
calcium, which is critical for lysosomal exocytosis. The release of
lysosomal proteases with known antimicrobial activity contributes
to the control of extracellular bacteria. In addition to the effect
of lysosomal contents in the extracellular compartment, recent
data from our group demonstrated that cytosolic flagellin is
also able to activate a lysosomal pathway that culminates in an
inflammasome-independent inflammatory form of cell death.
This inflammasome-independent cell death induced by cytoso-
lic flagellin is regulated by cathepsins B and D and is tempo-
rally correlated with the restriction of S. typhimurium infection
by macrophages (27). Together, these data indicate a cross talk
between lysosomes and NAIP/NLRC4 inflammasomes that impact
the control of bacterial infections and opens new avenues for the
development of inflammasome-based therapeutic strategies for
non-infectious pathologies such as tumors. In fact, lysosomes have
been considered important targets for the development of anti-
tumor drugs (112). Lysosomes from cancer cells appear to be less
stable than normal cells, which has given rise to the development
of therapies based on lysosomotropic detergents. In this sense, fla-
gellin could be an alternative that in addition to the induction of
lysosomal cell death, is able to mediate several effector mechanisms
as described throughout this review (Figure 1).
CONCLUSION AND FUTURE DIRECTIONS
More than 10 years after their discovery (14, 15), the molecular
mechanisms involved in the activation of NAIP/NLRC4 began
to be elucidated (18, 19, 26). From two distinct inflammasome
complexes, NAIPs emerged as universal sensors for cytosolic bacte-
rial proteins,whereas NLRC4 became an adaptor molecule respon-
sible for the recruitment and activation of caspase-1. At the same
time, in addition to NAIP5, novel NAIPs members were described,
FIGURE 1 | Cytosolic pathways induced by flagellin. Flagellin
delivered to cell cytosol through bacterial secretion systems or
transfection agents activates different pathways. (A) NAIP5/6-NLRC4
activation induces a series of cellular and humoral responses involved in
host control of infections. (B) In resting cells, NLRC4 is complexed with
Beclin-1, thus inhibiting autophagy. When flagellin is detected by
NAIP5/6, NLRC4 is recruited to assembly inflammasome complex and
release Beclin-1 to initiate autophagy. As a host protection response,
autophagy is able to eliminate cytosolic cargo and inhibits pyroptosis,
thus preventing cell loss and inflammation. Therefore, these emerging
effector responses induced by flagellin open up new avenues to explore
its immune potential as therapeutic targets. (C) Lysosomal destabilization
leads to cathepsins release to cell cytosol, resulting in the induction of
inflammasome-independent cell death that contributes to macrophage
control of infection and regulation of NAIP5/NLRC4-dependent
responses.
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amplifying the potential of these proteins to detect bacterial infec-
tions (18, 19, 113, 114). Despite this important information,
the molecular signatures of agonists recognized by NAIP/NLRC4
inflammasomes still require further study. Moreover, NLRC4 has
been associated with host resistance against a mucosal Candida
albicans infection (115) and in a colitis-associated colorectal can-
cer (CAC) model (116, 117). Interestingly, in both cases, NLRC4
seems to exert a protective role in non-hematopoietic compart-
ments. However, the precise mechanism of NLRC4 activation
in these models is unknown, raising the possibility that NLRC4
functions as an adaptor molecule for other NLR members in
addition to NAIP and providing new insights into inflammasome
signaling.
NAIP/NLRC4 are most likely the best-studied inflammasomes
in the context of host resistance against infections. In addition to
the extensively described IL-1β and IL-18 secretion and pyroptosis,
other important effector mechanisms mediated by these inflam-
masomes have recently emerged (Figure 1). Moreover, flagellin,
the best studied NAIP/NLRC4 ligand, has been reported to activate
distinct pathways, such as autophagy (95) and a lysosome path-
way (27) (Figure 1). Although the precise mechanism involved
in the lysosome disruption by flagellin is still under investiga-
tion, it culminates in an inflammatory process of cell death that
is accompanied by IL-1α secretion and contributes to the con-
trol of S. typhimurium by macrophages. This peculiar process of
cell death occurs in the absence of inflammasome components.
Additionally, the inhibition of cathepsin B disrupted IL-1β secre-
tion and pyroptosis in response to cytosolic flagellin, indicating
a role for lysosomal proteases in the regulation of NAIP/NLRC4-
dependent responses. Because human cells do not express NAIP5
or NAIP6 (18), the activation of the lysosomal pathway by flagellin
might be an alternative pathway used when human cells inter-
act with flagellated bacteria that reach cell cytosol. In the context
of therapeutic strategies, this knowledge could be an important
gain, as the immune properties of flagellin have been extensively
exploited in different models. At least in the context of anti-
tumor vaccination (118) and antibody production (90, 91), the
protective and adjuvancy roles of flagellin require its cytosolic
detection. Together, these reports open up new avenues to explore
the immune potential of NAIP/NLRC4 agonists as therapeutic
targets.
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